博济医药 (300404)

Boji Medical Technology Co., Ltd.

ASZ

Tags

Contract Research Organization (CXO)DeepSeekSpecialized-Sophisticated-Distinctive-Innovative EnterprisesBrain-Computer InterfaceImmunotherapyInnovative DrugsMedical ServicesHelicobacter PyloriMicro and Small Cap StocksMicro Cap Selected StocksR&DShareholder ReductionHigh Price-to-Earnings RatioSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexStocks Below Placement PriceInsurance Heavy HoldingsScientific Research IndexGuangdong

K-Line Chart

No K-line data available

Company NameBoji Pharmaceutical Technology Co., Ltd.
Listing Date2015-04-24
Issue Price12.87RMB
Registered Capital38555.607810k RMB
Legal RepresentativeWang Tingchun
Registered AddressBuilding 2345, No. 62 Nanxiang 1st Road, Science City, Huangpu District, Guangzhou, Guangdong Province
IndustryMedical Services
Main BusinessProvides full-process "one-stop" CRO services for domestic and foreign pharmaceutical companies and other research institutions in the research and development and production of drugs, health products, and medical devices.
Company ProfileBoji Pharmaceutical Technology Co., Ltd. (referred to as "Boji Pharmaceutical") was established in 2002 and is a new high-tech enterprise engaged in new drug R&D outsourcing services. Since its inception, Boji Pharmaceutical has consistently adhered to the business philosophy of "Honesty, Integrity, Professionalism, and Authority," providing pharmaceutical companies and other new drug R&D institutions with full-process "one-stop" outsourcing services for new drug R&D. These services include pharmaceutical research, drug evaluation (animal), clinical trials, post-marketing re-evaluation, technology achievement transformation, data management and statistical analysis, as well as registration and clinical research services for medical devices and health products.

Stock Details

1. Key Indicators

  • Total Shares(W): 38573.25
  • Circulating A-Shares(W): 28078.08
  • Earnings Per Share(RMB): 0.0571
  • Net Assets Per Share(RMB): 2.6462
  • Operating Revenue(W RMB): 58431.77
  • Total Profit(W RMB): 1833.06
  • Net Profit Attributable to Parent(W RMB): 2191.39
  • Net Profit Growth Rate(%): -49.36
  • Weighted Return on Equity(%): 2.2100
  • Operating Cash Flow Per Share(RMB): 0.0200
  • Undistributed Profit Per Share(RMB): 0.5802
  • Capital Reserve Per Share(RMB): 1.0203

2. Main Business

The main business covers:

  • Professional CRO service provider
  • Provides full-process "one-stop" CRO services for domestic and foreign pharmaceutical companies and other research institutions in the research, development, and production of new drugs and medical devices

3. Company Basic Information

  • Company Name: Boji Medical Technology Co., Ltd.
  • Listing Date: 2015-04-24
  • Industry: Research and Experimental Development
  • Address: 7th Floor, Building A, Vanke Cloud Plaza, No. 1933 Huaguan Road, Tianhe District, Guangzhou City, Guangdong Province
  • Website: www.gzboji.com
  • Company Profile: On May 26, 2011, Boji Limited held a shareholders' meeting and resolved to transform Boji Limited into a joint stock company based on the audited net assets of Boji Limited as of March 31, 2011 (the base date). The audited net assets of Boji Limited as of the base date were 105,545,228.15 yuan, which were converted into 50,000,000 shares at a conversion ratio of 1:0.4737, with a par value of 1.00 yuan per share, resulting in a total share capital of 50,000,000.00 yuan. The remaining 55,545,228.15 yuan was included in the company's capital reserve. On May 27, 2011, Zhengzhong Zhujiang verified the receipt of the registered capital of Boji Medical and issued the "Capital Verification Report" (Guanghuisuo Yanzi [2011] No. 10005790069). On June 11, 2011, the company held its founding meeting and resolved to establish the joint stock company. On June 30, 2011, the company obtained the business license (Registration No.: 440106000113076) from the Guangzhou Administration for Industry and Commerce, with a registered capital of 50 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hengqin Guangjin Meihao Fund Management Co., Ltd. - Guangjin Meihao Fermi No. 13 Private Securities Investment Fund Private Securities Investment Fund 503.67 1.79
2 Gongqingcheng Yinyi Investment Partnership (Limited Partnership) General Legal Person 265.97 0.95
3 Gongqingcheng Yinchi Investment Partnership (Limited Partnership) General Legal Person 256.63 0.91
4 Tibet East Wealth Vision Growth Hybrid Initiated Securities Investment Fund Class A Fund 7.87 0.03

5. Concept Sectors

  • Immunotherapy
  • Artificial Intelligence
  • CXO Concept
  • Brain-Computer Interface
  • Helicobacter Pylori
  • Hepatitis Concept
  • Innovative Drugs
  • Weight Loss Drugs
  • DeepSeek
  • AI Medical
  • High P/E Ratio
  • Shareholder Reduction
  • Specialized and Sophisticated SMEs
  • Micro-cap Selection
  • Micro and Small Cap Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information